Entry |
|
Name |
Mavodelpar sodium (USAN) |
Formula |
C31H29FNO5. Na
|
Exact mass |
537.1927
|
Mol weight |
537.55
|
Structure |
|
Remark |
|
Efficacy |
Peroxisome proliferator-activated receptor (PPAR) delta agonist |
Comment |
Treatment of fatty acid oxidation disorders
|
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C3 (PPARG)
D12645 Mavodelpar sodium (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 39
1 O2a O 21.0626 -12.5256
2 C8y C 22.2522 -13.2254
3 C8x C 22.2522 -14.6249
4 C8y C 23.5118 -15.3246
5 C8y C 24.7014 -14.6249
6 C8x C 24.7014 -13.2254
7 C8x C 23.5118 -12.5256
8 C1a C 23.5118 -16.7242
9 O2a O 25.9609 -15.3246
10 C1b C 27.1505 -14.6249
11 C6a C 28.3401 -15.3246
12 O6a O 29.5297 -14.6249 #-
13 O6a O 28.3401 -16.7242
14 C1b C 19.8731 -13.1554
15 C2b C 19.8731 -14.5549
16 C2c C 18.6835 -15.2547
17 C8y C 17.4939 -14.6249
18 C8y C 18.6835 -16.7242
19 C8x C 17.4939 -17.3539
20 C8x C 17.4939 -18.7534
21 C8y C 18.6835 -19.4532
22 C8x C 19.8731 -18.8234
23 C8x C 19.8731 -17.4239
24 X F 18.6835 -20.9227
25 C8x C 17.4939 -13.1554
26 C8x C 16.3043 -12.4556
27 C8y C 15.0447 -13.1554
28 C8x C 15.0447 -14.6249
29 C8x C 16.3043 -15.3246
30 C3b C 13.8552 -12.4556
31 C3b C 12.6656 -11.7559
32 C1b C 11.4060 -11.0561
33 N1y N 10.2164 -11.7559
34 C1x C 9.0268 -11.1261
35 C1x C 7.7673 -11.8259
36 O2x O 7.7673 -13.2254
37 C1x C 9.0268 -13.8552
38 C1x C 10.2164 -13.1554
39 Z Na 29.0500 -12.5335 #+
BOND 41
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 5 6 1
6 6 7 2
7 2 7 1
8 4 8 1
9 5 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 11 13 2
14 1 14 1
15 14 15 1
16 15 16 2
17 16 17 1
18 16 18 1
19 18 19 2
20 19 20 1
21 20 21 2
22 21 22 1
23 22 23 2
24 18 23 1
25 21 24 1
26 17 25 2
27 25 26 1
28 26 27 2
29 27 28 1
30 28 29 2
31 17 29 1
32 27 30 1
33 30 31 3
34 31 32 1
35 32 33 1
36 33 34 1
37 34 35 1
38 35 36 1
39 36 37 1
40 37 38 1
41 33 38 1
|